Sign Up to like & get
recommendations!
0
Published in 2018 at "Medicine"
DOI: 10.1097/md.0000000000013104
Abstract: Rationale: Rivaroxaban is a non-vitamin K antagonist oral anticoagulant. Current recommendations state that coagulation monitoring is not required, and neither the dose nor dosing interval requires adjustment in response to changes in coagulation parameters when…
read more here.
Keywords:
caused rivaroxaban;
coagulation;
routine coagulation;
coagulation test ... See more keywords